Franco Locatelli

Faculty Profile Webpagehttps://docenti.unicatt.it/ppd2/linkPpdDocente?cod_docente=92192

Research activity per year

Academic discipline

MEDS-20/A - Paediatrics

Fingerprint

Dive into the research topics where Franco Locatelli is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

1 Similar Profiles

1244 Article
3 Chapter
2 Meeting Abstract
1 Editorial

131I-mIBG therapy in relapsed/refractory neuroblastoma: an old bridge to the future
De, I. M. A., Villani, M. F., Fabozzi, F., Del, B. F., Altini, C., Cefalo, M. G., Cannata, V., Del, B. G., Pizzoferro, M., Alessi, I., Lanzaro, F., Davide, C., Toma, P., D'Andrea, M. L., Di, G. A., Serra, A., Mastronuzzi, A., Garganese, M. C. & Locatelli, F., 2025, In: ESMO Open. 10, 4, p. 1-7 7 p.
Research output: Contribution to journal › Article
Circulating microRNAs: A remarkable opportunity as non-invasive biomarkers from adult to pediatric brain tumor patients
D'Antonio, F., Spinello, Z., Bargiacchi, L., Splendiani, E., Rossi, S., Masuelli, L., Mastronuzzi, A., Locatelli, F., Ferretti, E. & Catanzaro, G., 2025, In: Critical Reviews in Oncology/Hematology. 208, 208, p. 1-9 9 p.
Research output: Contribution to journal › Article
DNA methylation profiling from cerebrospinal fluid as a diagnostic tool for pineoblastoma
Antonacci, C., Abballe, L., Patrizi, S., Pedace, L., Barresi, S., Giovannoni, I., Tancredi, C., Vinciarelli, F., Megaro, G., Carai, A., Rossi, S., Locatelli, F., Mastronuzzi, A. & Miele, E., 2025, In: Acta neuropathologica communications. 13, 1, p. 1-6 6 p.
Research output: Contribution to journal › Article
Donor-derived GD2-specific CAR T cells in relapsed or refractory neuroblastoma
Quintarelli, C., Del, B. F., De, I. M. A., Guercio, M., Algeri, M., Pagliara, D., Silvestris, D. A., Di, N. M., Sinibaldi, M., Di, C. S., Iaffaldano, L., Manni, S., Fustaino, V., Garganese, M. C., Colafati, G. S., Bertaina, V., Becilli, M., Mastronuzzi, A., Fabozzi, F. & Gunetti, M. & 9 others, Iacovelli, S., Bugianesi, R., Macchia, S., Li, P. G., Cefalo, M. G., Leone, G., Del, B. G., De, A. B. & Locatelli, F., 2025, In: Nature Medicine. 31, 3, p. 849-860 12 p.
Research output: Contribution to journal › Article
Epigenomic characterization and therapeutic challenges of melanoma arising in giant nevi in pediatric patients
Miele, E., Rossi, S., Stracuzzi, A., Patrizi, S., Barresi, S., Cajozzo, M., Pedace, L., Giovannoni, I., Dell'Otto, F., Diociaiuti, A., Grussu, F., Vinciarelli, F., Crocoli, A., Castellano, A., Garganese, M. C., Mastronuzzi, A., Locatelli, F., Alaggio, R., Hachem, M. E. & Zama, M. & 1 others, De, P. M. D., 2025, In: Discover Oncology. 16, 1, p. 1-12 12 p.
Research output: Contribution to journal › Article

Safe and effective off-the-shelf immunotherapy based on CAR.CD123-NK cells for the treatment of acute myeloid leukaemia
Caruso, S. (Creator), De Angelis, B. (Creator), Del Bufalo, F. (Creator), Ciccone, R. (Creator), Donsante, S. (Creator), Volpe, G. (Creator), Manni, S. (Creator), Guercio, M. (Creator), Pezzella, M. (Creator), Iaffaldano, L. (Creator), Silvestris, D. A. (Creator), Sinibaldi, M. (Creator), Di Cecca, S. (Creator), Pitisci, A. (Creator), Velardi, E. (Creator), Merli, P. (Creator), Algeri, M. (Creator), Lodi, M. (Creator), Paganelli, V. (Creator), Serafini, M. (Creator), Riminucci, M. (Creator), Locatelli, F. (Creator) & Quintarelli, C. (Creator), figshare, 2022
DOI: 10.6084/m9.figshare.c.6285717, https://springernature.figshare.com/collections/Safe_and_effective_off-the-shelf_immunotherapy_based_on_CAR_CD123-NK_cells_for_the_treatment_of_acute_myeloid_leukaemia/6285717
Dataset
sj-tif-3-tah-10.1177_20406207231201454 – Supplemental material for Survival outcomes in patients with relapsed/refractory or MRD-positive B-cell acute lymphoblastic leukemia treated with blinatumomab
Kantarjian, H. M. (Creator), Logan, A. C. (Creator), Zaman, F. (Creator), Gökbuget, N. (Creator), Bargou, R. C. (Creator), Zeng, Y. (Creator), Zugmaier, G. (Creator) & Locatelli, F. (Creator), SAGE Journals, 2023
DOI: 10.25384/sage.24276679, https://sage.figshare.com/articles/figure/sj-tif-3-tah-10_1177_20406207231201454_Supplemental_material_for_Survival_outcomes_in_patients_with_relapsed_refractory_or_MRD-positive_B-cell_acute_lymphoblastic_leukemia_treated_with_blinatumomab/24276679
Dataset
sj-tif-4-tah-10.1177_20406207231201454 – Supplemental material for Survival outcomes in patients with relapsed/refractory or MRD-positive B-cell acute lymphoblastic leukemia treated with blinatumomab
Kantarjian, H. M. (Creator), Logan, A. C. (Creator), Zaman, F. (Creator), Gökbuget, N. (Creator), Bargou, R. C. (Creator), Zeng, Y. (Creator), Zugmaier, G. (Creator) & Locatelli, F. (Creator), SAGE Journals, 2023
DOI: 10.25384/sage.24276682, https://sage.figshare.com/articles/figure/sj-tif-4-tah-10_1177_20406207231201454_Supplemental_material_for_Survival_outcomes_in_patients_with_relapsed_refractory_or_MRD-positive_B-cell_acute_lymphoblastic_leukemia_treated_with_blinatumomab/24276682
Dataset
Immune dysregulation associated with co-occurring germline CBL and SH2B3 variants
Baccelli, F. (Creator), Leardini, D. (Creator), Muratore, E. (Creator), Messelodi, D. (Creator), Bertuccio, S. N. (Creator), Chiriaco, M. (Creator), Cancrini, C. (Creator), Conti, F. (Creator), Castagnetti, F. (Creator), Pedace, L. (Creator), Pession, A. (Creator), Yoshimi, A. (Creator), Niemeyer, C. (Creator), Tartaglia, M. (Creator), Locatelli, F. (Creator) & Masetti, R. (Creator), figshare, 2022
DOI: 10.6084/m9.figshare.c.6206856.v1, https://springernature.figshare.com/collections/Immune_dysregulation_associated_with_co-occurring_germline_CBL_and_SH2B3_variants/6206856/1
Dataset
sj-tif-4-tah-10.1177_20406207231201454 – Supplemental material for Survival outcomes in patients with relapsed/refractory or MRD-positive B-cell acute lymphoblastic leukemia treated with blinatumomab
Kantarjian, H. M. (Creator), Logan, A. C. (Creator), Zaman, F. (Creator), Gökbuget, N. (Creator), Bargou, R. C. (Creator), Zeng, Y. (Creator), Zugmaier, G. (Creator) & Locatelli, F. (Creator), SAGE Journals, 2023
DOI: 10.25384/sage.24276682.v1, https://sage.figshare.com/articles/figure/sj-tif-4-tah-10_1177_20406207231201454_Supplemental_material_for_Survival_outcomes_in_patients_with_relapsed_refractory_or_MRD-positive_B-cell_acute_lymphoblastic_leukemia_treated_with_blinatumomab/24276682/1
Dataset

Franco Locatelli

Personal profile

Academic discipline

Fingerprint

Collaborations and top research areas from the last five years

Dive into details

131I-mIBG therapy in relapsed/refractory neuroblastoma: an old bridge to the future

Circulating microRNAs: A remarkable opportunity as non-invasive biomarkers from adult to pediatric brain tumor patients

DNA methylation profiling from cerebrospinal fluid as a diagnostic tool for pineoblastoma

Donor-derived GD2-specific CAR T cells in relapsed or refractory neuroblastoma

Epigenomic characterization and therapeutic challenges of melanoma arising in giant nevi in pediatric patients

Safe and effective off-the-shelf immunotherapy based on CAR.CD123-NK cells for the treatment of acute myeloid leukaemia

sj-tif-3-tah-10.1177_20406207231201454 – Supplemental material for Survival outcomes in patients with relapsed/refractory or MRD-positive B-cell acute lymphoblastic leukemia treated with blinatumomab

sj-tif-4-tah-10.1177_20406207231201454 – Supplemental material for Survival outcomes in patients with relapsed/refractory or MRD-positive B-cell acute lymphoblastic leukemia treated with blinatumomab

Immune dysregulation associated with co-occurring germline CBL and SH2B3 variants

sj-tif-4-tah-10.1177_20406207231201454 – Supplemental material for Survival outcomes in patients with relapsed/refractory or MRD-positive B-cell acute lymphoblastic leukemia treated with blinatumomab

Franco Locatelli

Personal profile

Academic discipline

Fingerprint

Collaborations and top research areas from the last five years

Research output

Datasets